Collection of blood and tissue samples for liver disease research
Part of Cancer, Digestive system, Infections clinical trials.
This study builds a research library of biological samples (like tissue and blood) from people with chronic liver disease. It aims to create better lab and preclinical models of tumors and long-term liver problems, which may help future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic liver disease, from any cause (including viral or not)
- You have at least one liver nodule where your care plan includes a biopsy
- Your care plan includes liver-related procedures like surgery or a treatment for liver cancer
- You can understand the study and sign consent in writing
- You are covered by the French social security system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with liver disease linked to alcohol use or metabolic syndrome (a cluster of conditions like weight gain and insulin resistance). It uses recent standard-of-care liver biopsy results to better understand these chronic liver problems and how they relate to cancer risk.
This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.
This study collects blood samples to build a “biobank” (a stored library of samples) for researchers studying liver diseases like hepatitis, fatty liver disease, and liver cancer. It may help future testing and treatments by allowing scientists to study patterns in people with and without liver conditions.
This study collects health information from people with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver. It aims to learn more about the disease to improve future care.
This study collects blood and tumor tissue samples from people with primary liver cancer who are starting their first treatment (systemic therapy or surgery). The samples help researchers learn more about these cancers and how to improve future treatments.
This trial looks at tiny particles in the blood (extracellular vesicles) to see if they can help doctors understand and track liver disease. It includes healthy volunteers, people with diabetes and liver scarring, and people with cirrhosis, with the goal of finding better biomarkers.
Hear when a new Chronic Liver Disease and Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.